-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR47 at Berenberg
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR45 at Deutsche Bank
-
Bernstein SocGen Group Reinstates Carl Zeiss Meditec AG (AFX:GR) (CZMWY) at Outperform
-
Goldman Sachs Upgrades Carl Zeiss Meditec AG (AFX:GR) (CZMWY) to Buy
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Raised to EUR41 at JPMorgan
-
Goldman Sachs Upgrades Carl Zeiss Meditec AG (AFX:GR) (CZMWY) to Neutral
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR55 at Deutsche Bank
-
European MedTech 2025 outlook
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR85 at RBC Capital
-
UBS Downgrades Carl Zeiss Meditec AG (AFX:GR) (CZMWY) to Neutral
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR97.70 at Baader Helvea
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR65 at Stifel
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR56 at JPMorgan
-
Carl Zeiss Meditec AG (AFX:GR) (CZMWY) PT Lowered to EUR75 at Deutsche Bank

